How to Measure Oestrogen Receptor Activity
Author Information
Author(s): RA Hawkins
Primary Institution: University Department of Surgery, Royal Infirmary of Edinburgh Trust
Hypothesis
What is the best way to express oestrogen receptor activity in breast cancer?
Conclusion
Different methods of measuring oestrogen receptor activity are important for predicting treatment outcomes in breast cancer.
Supporting Evidence
- 70-100% of breast cancers have oestrogen receptors depending on the method used.
- Immunohistochemical staining assays allow for better assessment of receptor activity.
- All modes of expressing IHA results were significantly related to treatment outcomes.
Takeaway
This study looks at how to measure a specific protein in breast cancer that helps doctors decide on treatment. They found that using more categories to describe the protein levels can give better information about how well treatment might work.
Methodology
The study examined six different methods of expressing immunohistochemical assay results for oestrogen receptors in breast cancer patients treated with tamoxifen.
Limitations
The study compares results from assays performed 17 years apart, which may not be entirely fair.
Participant Demographics
The participants included 133 with operable primary disease, 23 with locally advanced disease, and 14 with distant metastases.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website